Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

Michot JM, Lazarovici J, Tieu A, Champiat S, Voisin AL, Ebbo M, Godeau B, Michel M, Ribrag V, Lambotte O.

Eur J Cancer. 2019 Oct 17;122:72-90. doi: 10.1016/j.ejca.2019.07.014. [Epub ahead of print] Review.

PMID:
31634647
2.

HIV controllers: to treat or not to treat? Is that the right question?

Noël N, Saez-Cirion A, Avettand-Fenoël V, Boufassa F, Lambotte O.

Lancet HIV. 2019 Oct 14. pii: S2352-3018(19)30264-4. doi: 10.1016/S2352-3018(19)30264-4. [Epub ahead of print] Review.

PMID:
31624011
3.

HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry.

Paoletti A, Allouch A, Caillet M, Saïdi H, Subra F, Nardacci R, Wu Q, Muradova Z, Voisin L, Raza SQ, Law F, Thoreau M, Dakhli H, Delelis O, Poirier-Beaudouin B, Dereuddre-Bosquet N, Le Grand R, Lambotte O, Saez-Cirion A, Pancino G, Ojcius DM, Solary E, Deutsch E, Piacentini M, Gougeon ML, Kroemer G, Perfettini JL.

Cell Rep. 2019 Sep 24;28(13):3381-3394.e7. doi: 10.1016/j.celrep.2019.02.095.

4.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

Hage-Sleiman M, Tremeaux P, Fillion M, Boufassa F, Melard A, Gardiennet E, Mariaggi AA, Plantier JC, Rouzioux C, Lambotte O, Avettand-Fenoel V; CODEX ANRS Cohort Study Group .

Clin Infect Dis. 2019 Sep 21. pii: ciz734. doi: 10.1093/cid/ciz734. [Epub ahead of print]

PMID:
31541253
5.

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.

Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B.

Am J Hematol. 2019 Sep 5. doi: 10.1002/ajh.25632. [Epub ahead of print]

PMID:
31489694
6.

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).

Ramos-Casals M, Maria A, Suárez-Almazor ME, Lambotte O, Fisher BA, Hernández-Molina G, Guilpain P, Pundole X, Flores-Chávez A, Baldini C, Bingham Iii CO, Brito-Zerón P, Gottenberg JE, Kostine M, Radstake TRD, Schaeverbeke T, Schulze-Koops H, Calabrese L, Khamashta MA, Mariette X; ICIR.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):114-122. Epub 2019 Aug 28.

7.

Characterization of Leukocytes From HIV-ART Patients Using Combined Cytometric Profiles of 72 Cell Markers.

Leite Pereira A, Tchitchek N, Lambotte O, Le Grand R, Cosma A.

Front Immunol. 2019 Aug 6;10:1777. doi: 10.3389/fimmu.2019.01777. eCollection 2019.

8.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, Brosselin P, De Vergnes N, Debré M, Malphettes M, Frange P, Catherinot E, Pellier I, Durieu I, Perlat A, Royer B, Le Quellec A, Jeziorski E, Fischer A, Lortholary O; CEREDIH French PID study group, Aaron L, Adoue D, Aguilar C, Aladjidi N, Alcais A, Amoura Z, Arlet P, Armari-Alla C, Bader-Meunier B, Bayart S, Bertrand Y, Bienvenu B, Blanche S, Bodet D, Bonnotte B, Borie R, Boutard P, Briandet C, Brion JP, Brouard J, Cohen-Beaussant S, Costes L, Couderc LJ, Cougoul P, Courteille V, de Saint Basile G, Devoldere C, Deville A, Donadieu J, Dore E, Dulieu F, Edan C, Entz-Werle N, Fieschi C, Forestier A, Fouyssac F, Gajdos V, Galicier L, Gandemer V, Gardembas M, Gaud C, Guillerm G, Hachulla E, Hamidou M, Hermine O, Hoarau C, Humbert S, Jaccard A, Jacquot S, Jais JP, Jaussaud R, Jeandel PY, Kebaili K, Korganow AS, Lambotte O, Lanternier F, Larroche C, Lascaux AS, Le Moigne E, Le Moing V, Lebranchu Y, Lecuit M, Lefevre G, Lemal R, Te VLT, Marie-Cardine A, Silva NM, Masseau A, Massot C, Mazingue F, Merlin E, Michel G, Millot F, Monlibert B, Monpoux F, Moshous D, Mouthon L, Munzer M, Neven B, Nove-Josserand R, Oksenhendler E, Ouachée-Chardin M, Oudot C, Pagnier A, Pasquali JL, Pasquet M, Perel Y, Picard C, Piguet C, Plantaz D, Provot J, Quartier P, Rieux-Laucat F, Roblot P, Roger PM, Rohrlich PS, Rubie H, Salle V, Sarrot-Reynauld F, Servettaz A, Stephan JL, Schleinitz N, Suarez F, Swiader L, Taque S, Thomas C, Tournilhac O, Thumerelle C, Tron F, Vannier JP, Viallard JF.

J Clin Immunol. 2019 Oct;39(7):702-712. doi: 10.1007/s10875-019-00658-9. Epub 2019 Aug 10.

PMID:
31401750
9.

The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients.

Henriquez S, Lecuroux C, Bitu M, Avettand-Fenoel V, Churaqui F, Catalan P, Cheret A, Boufassa F, Saez-Cirion A, Monceaux V, Meyer L, Goujard C, Lambotte O, Bourgeois C; ANRS CO6 PRIMO, the ANRS CO21 CODEX cohorts.

AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002342. [Epub ahead of print]

PMID:
31385864
10.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.

Tison A, Quéré G, Misery L, Funck-Brentano E, Danlos FX, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, De Quatrebarbes J, Michel C, Auliac JB, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M; Groupe de Cancérologie Cutanée, Groupe Français de Pneumo-Cancérologie, and Club Rhumatismes et Inflammations.

Arthritis Rheumatol. 2019 Aug 5. doi: 10.1002/art.41068. [Epub ahead of print]

PMID:
31379105
11.

Frontline Science: Exhaustion and senescence marker profiles on human T cells in BRGSF-A2 humanized mice resemble those in human samples.

Labarthe L, Henriquez S, Lambotte O, Di Santo JP, Le Grand R, Pflumio F, Arcangeli ML, Legrand N, Bourgeois C.

J Leukoc Biol. 2019 Aug 4. doi: 10.1002/JLB.5HI1018-410RR. [Epub ahead of print]

PMID:
31378988
12.

Mass Cytometry Reveals the Immaturity of Circulating Neutrophils during SIV Infection.

Lemaitre J, Cosma A, Desjardins D, Lambotte O, Le Grand R.

J Innate Immun. 2019 Jun 21:1-12. doi: 10.1159/000499841. [Epub ahead of print]

13.

Cardiovascular Events in the French ANRS HIV Controller Cohort.

Noël N, Gominet M, Meyer L, Boufassa F, Lambotte O.

J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):e32-e34. doi: 10.1097/QAI.0000000000002108. No abstract available.

PMID:
31192824
14.

Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: A case study and literature review.

Rohmer J, Groh M, Samson M, London J, Jachiet M, Rouzaud D, Paule R, Suarez F, Lefèvre G, Cohen F, Lambotte O, Perlat A, Bielefeld P, Guillevin L, Kahn JE, Terrier B; French Vasculitis Study Group (FVSG).

Autoimmun Rev. 2019 Aug;18(8):828-830. doi: 10.1016/j.autrev.2019.06.004. Epub 2019 Jun 7. No abstract available.

PMID:
31176876
15.

Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.

Simonaggio A, Michot JM, Voisin AL, Le Pavec J, Collins M, Lallart A, Cengizalp G, Vozy A, Laparra A, Varga A, Hollebecque A, Champiat S, Marabelle A, Massard C, Lambotte O.

JAMA Oncol. 2019 Jun 6. doi: 10.1001/jamaoncol.2019.1022. [Epub ahead of print]

PMID:
31169866
16.

Cynomolgus macaque IL37 polymorphism and control of SIV infection.

Shiina T, Suzuki S, Congy-Jolivet N, Aarnink A, Garchon HJ, Dereuddre-Bosquet N, Vaslin B, Tchitchek N, Desjardins D, Autran B, Lambotte O, Theodorou I, Le Grand R, Blancher A.

Sci Rep. 2019 May 28;9(1):7981. doi: 10.1038/s41598-019-44235-x.

17.

[Management of adverse events associated with cancer immunotherapy].

Champiat S, Michot JM, Lambotte O.

Rev Prat. 2019 Jan;69(1):39-48. Review. French.

PMID:
30983283
18.

Impact of HIV/simian immunodeficiency virus infection and viral proteins on adipose tissue fibrosis and adipogenesis.

Gorwood J, Bourgeois C, Mantecon M, Atlan M, Pourcher V, Pourcher G, Le Grand R, Desjardins D, Fève B, Lambotte O, Capeau J, Béréziat V, Lagathu C.

AIDS. 2019 May 1;33(6):953-964. doi: 10.1097/QAD.0000000000002168.

PMID:
30946149
19.

Inherited Thrombotic Thrombocytopenic Purpura Revealed by Recurrent Strokes in a Male Adult: Case Report and Literature Review.

Beauvais D, Venditti L, Chassin O, Joly B, Ameri A, Boisseau P, Lambotte O, Coppo P, Veyradier A, Denier C.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1537-1539. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.011. Epub 2019 Mar 28. Review.

PMID:
30930238
20.

CytoBackBone: an algorithm for merging of phenotypic information from different cytometric profiles.

Leite Pereira A, Lambotte O, Le Grand R, Cosma A, Tchitchek N.

Bioinformatics. 2019 Oct 15;35(20):4187-4189. doi: 10.1093/bioinformatics/btz212.

21.

HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.

Hocini H, Bonnabau H, Lacabaratz C, Lefebvre C, Tisserand P, Foucat E, Lelièvre JD, Lambotte O, Saez-Cirion A, Versmisse P, Thiébaut R, Lévy Y.

J Virol. 2019 May 1;93(10). pii: e01690-18. doi: 10.1128/JVI.01690-18. Print 2019 May 15.

PMID:
30814287
22.

The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models.

Laparra A, Tricot S, Le Van M, Damouche A, Gorwood J, Vaslin B, Favier B, Benoist S, Ho Tsong Fang R, Bosquet N, Le Grand R, Chapon C, Lambotte O, Bourgeois C.

Front Immunol. 2019 Feb 5;10:117. doi: 10.3389/fimmu.2019.00117. eCollection 2019.

23.

Neurotoxicity induced by targeted therapies in patients treated for metastatic melanoma.

Velter C, Libenciuc C, Routier E, Mateus C, Fahmy J, Ghoufi L, Lambotte O, Not A, Cauquil C, Claveau S, Claveau J, Robert C.

Eur J Cancer. 2019 Apr;111:8-11. doi: 10.1016/j.ejca.2019.01.017. Epub 2019 Feb 22. No abstract available.

PMID:
30798086
24.

Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy.

Bitton K, Michot JM, Barreau E, Lambotte O, Haigh O, Marabelle A, Voisin AL, Mateus C, Rémond AL, Couret C, Champiat S, Labetoulle M, Rousseau A.

Am J Ophthalmol. 2019 Jun;202:109-117. doi: 10.1016/j.ajo.2019.02.012. Epub 2019 Feb 15.

PMID:
30772350
25.

Renal toxicities associated with pembrolizumab.

Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I.

Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 9.

26.

Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab.

Dutertre M, de Menthon M, Noël N, Albiges L, Lambotte O.

Eur J Cancer. 2019 Mar;110:21-23. doi: 10.1016/j.ejca.2019.01.009. Epub 2019 Feb 7. No abstract available.

PMID:
30739836
27.

Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?

Kostine M, Cappelli LC, Calabrese C, Calabrese LH, Bingham CO 3rd, Richez C, Gottenberg JE, Lambotte O.

Ann Rheum Dis. 2019 Jun;78(6):860-862. doi: 10.1136/annrheumdis-2018-214748. Epub 2019 Jan 18. No abstract available.

PMID:
30659050
28.

Dynamics in HIV-DNA levels over time in HIV controllers.

Avettand-Fenoel V, Bayan T, Gardiennet E, Boufassa F, Lopez P, Lecuroux C, Noel N, Trémeaux P, Monceaux V, Autran B, Meyer L, Saez-Cirion A, Lambotte O, Rouzioux C; CODEX ANRS Cohort Study Group.

J Int AIDS Soc. 2019 Jan;22(1):e25221. doi: 10.1002/jia2.25221.

29.

Methemoglobinemia as a biomarker of dapsone-induced mania severity.

Colle R, Ait Tayeb AEK, Mesdom P, de Menthon M, Becquemont L, Verstuyft C, David DJ, Lambotte O, Corruble E.

J Affect Disord. 2019 Jul 1;254:122-123. doi: 10.1016/j.jad.2018.12.123. Epub 2018 Dec 25.

PMID:
30598189
30.

Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection.

Valle-Casuso JC, Angin M, Volant S, Passaes C, Monceaux V, Mikhailova A, Bourdic K, Avettand-Fenoel V, Boufassa F, Sitbon M, Lambotte O, Thoulouze MI, Müller-Trutwin M, Chomont N, Sáez-Cirión A.

Cell Metab. 2019 Mar 5;29(3):611-626.e5. doi: 10.1016/j.cmet.2018.11.015. Epub 2018 Dec 20.

PMID:
30581119
31.

A composite lymphoma combining a Hodgkin lymphoma and a marginal zone lymphoma transformed into a diffuse large B-cell lymphoma.

Auditeau C, Lambotte O, Feriel J, Lazure T, Turhan A, Aumont C.

Clin Case Rep. 2018 Oct 22;6(12):2341-2346. doi: 10.1002/ccr3.1841. eCollection 2018 Dec.

32.

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Delanoy N, Michot JM, Comont T, Kramkimel N, Lazarovici J, Dupont R, Champiat S, Chahine C, Robert C, Herbaux C, Besse B, Guillemin A, Mateus C, Pautier P, Saïag P, Madonna E, Maerevoet M, Bout JC, Leduc C, Biscay P, Quere G, Nardin C, Ebbo M, Albigès L, Marret G, Levrat V, Dujon C, Vargaftig J, Laghouati S, Croisille L, Voisin AL, Godeau B, Massard C, Ribrag V, Marabelle A, Michel M, Lambotte O.

Lancet Haematol. 2019 Jan;6(1):e48-e57. doi: 10.1016/S2352-3026(18)30175-3. Epub 2018 Dec 4.

PMID:
30528137
33.

Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2019 Mar;70(3):566-567. doi: 10.1016/j.jhep.2018.11.016. Epub 2018 Dec 5. No abstract available.

PMID:
30527952
34.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
35.

Reply to: "Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study".

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Dec;69(6):1397-1398. doi: 10.1016/j.jhep.2018.09.006. Epub 2018 Oct 5. No abstract available.

PMID:
30297274
36.

A high-resolution mass cytometry analysis reveals a delay of cytokines production after TLR4 or TLR7/8 engagements in HIV-1 infected humans.

Leite Pereira A, Tchitchek N, Marcos Lopez E, Lambotte O, Le Grand R, Cosma A.

Cytokine. 2018 Nov;111:97-105. doi: 10.1016/j.cyto.2018.08.018. Epub 2018 Aug 20.

37.

Reply to: "Mortality due to immunotherapy related hepatitis".

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Oct;69(4):978-979. doi: 10.1016/j.jhep.2018.07.009. Epub 2018 Aug 7. No abstract available.

PMID:
30097327
38.

Does Quality of Life and Sexual Quality of Life in HIV Patients Differ Between Non-treated HIV Controllers and Treated Patients in the French ANRS VESPA 2 National Survey?

Préau M, Mora M, Puppo C, Laguette V, Sagaon-Teyssier L, Boufassa F, Meyer L, Lambotte O, Spire B.

AIDS Behav. 2019 Jan;23(1):132-139. doi: 10.1007/s10461-018-2237-8.

PMID:
30073634
39.

[Is it possible to use immune checkpoint inhibitors in patients with autoimmune or inflammatory disease?]

Danlos FX, Lambotte O.

Med Sci (Paris). 2018 Jun-Jul;34(6-7):516-518. doi: 10.1051/medsci/20183406007. Epub 2018 Jul 31. French. No abstract available.

40.

A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis.

Bigenwald C, Fardet L, Coppo P, Meignin V, Lazure T, Fabiani B, Kohn M, Oksenhendler E, Boutboul D, Uzzan M, Lambotte O, Galicier L.

Br J Haematol. 2018 Oct;183(1):68-75. doi: 10.1111/bjh.15506. Epub 2018 Jul 24.

PMID:
30043391
41.

Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.

Ploquin MJ, Casrouge A, Madec Y, Noël N, Jacquelin B, Huot N, Duffy D, Jochems SP, Micci L, Lécuroux C, Boufassa F, Booiman T, Garcia-Tellez T, Ghislain M, Grand RL, Lambotte O, Kootstra N, Meyer L, Goujard C, Paiardini M, Albert ML, Müller-Trutwin M.

J Int AIDS Soc. 2018 Jul;21(7):e25144. doi: 10.1002/jia2.25144.

42.

Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.

Dollat M, Chaigne B, Cormier G, Costedoat-Chalumeau N, Lifermann F, Deroux A, Berthoux E, Dernis E, Sené T, Blaison G, Lambotte O, Terrier B, Sellam J, De Saint-Martin L, Chiche L, Dupin N, Mouthon L.

BMC Infect Dis. 2018 Jul 4;18(1):302. doi: 10.1186/s12879-018-3227-1.

43.

Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a+ CD4+ T Cells From Early HIV Infection to Effective cART.

Coindre S, Tchitchek N, Alaoui L, Vaslin B, Bourgeois C, Goujard C, Avettand-Fenoel V, Lecuroux C, Bruhns P, Le Grand R, Beignon AS, Lambotte O, Favier B; ANRS CO6 PRIMO Cohort.

Front Immunol. 2018 Jun 4;9:1217. doi: 10.3389/fimmu.2018.01217. eCollection 2018.

44.

Bruising in a Depressed Patient: Self-Inflicted or Adverse Effect of Antidepressants?: An Unexpected Cause: Scurvy.

Lasica PA, Lavenu-Bombled C, Lambotte O, Gressier F.

J Clin Psychopharmacol. 2018 Aug;38(4):398-400. doi: 10.1097/JCP.0000000000000906. No abstract available.

PMID:
29912801
45.

Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.

Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O.

Ann Rheum Dis. 2019 Jul;78(7):e67. doi: 10.1136/annrheumdis-2018-213677. Epub 2018 Jun 1. No abstract available.

PMID:
29858173
46.

Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"

De Martin E, Michot JM, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Aug;69(2):550-551. doi: 10.1016/j.jhep.2018.04.019. No abstract available.

PMID:
29776713
47.

A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers.

Claireaux M, Galperin M, Benati D, Nouël A, Mukhopadhyay M, Klingler J, de Truchis P, Zucman D, Hendou S, Boufassa F, Moog C, Lambotte O, Chakrabarti LA.

MBio. 2018 May 8;9(3). pii: e00317-18. doi: 10.1128/mBio.00317-18.

48.

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.

Mekki A, Dercle L, Lichtenstein P, Marabelle A, Michot JM, Lambotte O, Le Pavec J, De Martin E, Balleyguier C, Champiat S, Ammari S.

Eur J Cancer. 2018 Jun;96:91-104. doi: 10.1016/j.ejca.2018.03.006. Epub 2018 Apr 23.

PMID:
29698933
49.

[The Script Concordance Test: A multimodal teaching tool].

Karila L, François H, Monnet X, Noel N, Roupret M, Gajdos V, Lambotte O, Benhamou D, Benyamina A.

Rev Med Interne. 2018 Jul;39(7):566-573. doi: 10.1016/j.revmed.2017.12.011. Epub 2018 Mar 22. Review. French.

PMID:
29576195
50.

Interferon-associated therapies toward HIV control: The back and forth.

Noël N, Jacquelin B, Huot N, Goujard C, Lambotte O, Müller-Trutwin M.

Cytokine Growth Factor Rev. 2018 Apr;40:99-112. doi: 10.1016/j.cytogfr.2018.03.004. Epub 2018 Mar 9. Review.

Supplemental Content

Loading ...
Support Center